Clinical trial NCT02502695: A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)
Official title: A Prospective, Observational, Quality Improvement Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Lung Cancer
Keywords: VATS Lobectomy and Segmentectomy for Lung Cancer
Lung Cancer
Lead sponsor: Dana-Farber Cancer Institute
Sponsor class: OTHER
Collaborators: name: Ethicon Endo-Surgery
First posted: 2015-07-20
Enrollment: 173
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Participants that will have VATS lobectomy and segmentectomy procedures for lung cancer

Brief summary: This is a research study for participants who have been diagnosed with lung cancer and are receiving VATS (Video Assisted Thoracoscopic Surgery) lobectomy or segmentectomy. The overall objective of this study is to develop a database to collect data on participants who are undergoing VATS lobectomy or segmentectomy for lung cancer.

Detailed description: This database will be used as for quality improvement purposes. Furthermore, the database will help in collecting data in an organized fashion, which will help the investigators learn more about the details of the workup performed prior to the surgery, during the surgery, peri-operative management and early follow-up. The investigators hope that this database will help to determine a common guideline to perform VATS lobectomy or segmentectomy. By creating a common guideline for future treatment of VATS patients, the investigators predict the efficiency of the process will increase significantly without decreasing, and perhaps even improving, the quality of the procedure.

Eligibility criteria: Inclusion Criteria:

* Male and female subjects
* Age ≥ 18 years
* Underwent a VATS lobectomy or segmentectomy procedure for lung cancer -- Note: patients with other malignancies are eligible if they have a primary cancer of the lung as defined above

Exclusion Criteria:

* Subjects undergoing thoracotomy lobectomy or segmentectomy for lung cancer
* Subjects undergoing surgical procedures other than VATS lobectomy or segmentectomy for lung cancer

Primary outcomes:
measure: Readmissions rates within 30 days of the patient's surgery date
timeFrame: 30 Days
measure: Incidence of post-operative complications within 30 days of the patient's surgery date
timeFrame: 30 Days
measure: Total inpatient cost
timeFrame: 30 Days
Secondary outcomes:
measure: Difference in readmission rates between the two cohorts
timeFrame: 3 years
Other outcomes:
Locations:
city: Santa Monica
country: United States
facility: Providence Saint John's Health Center
state: California
city: Washington
country: United States
facility: Georgetown University Medical Center
state: District of Columbia
city: Austell
country: United States
facility: WellStar Medical Group
state: Georgia
city: Evanston
country: United States
facility: North Shore University Health System
state: Illinois
city: Boston
country: United States
facility: Brigham and Women's Hospital
state: Massachusetts
city: Saint Louis
country: United States
facility: Washington University in St. Louis
state: Missouri
Study officials:
affiliation: Brigham and Women's Hospital
name: Scott J. Swanson, MD
role: PRINCIPAL_INVESTIGATOR
References: